Faster regs, more biosims, more biotech in China’s outline five-year plan
This article was originally published in Scrip
Executive Summary
A newly released five-year strategic plan from China's central government officially brings to the fore the importance of developing the country's biopharmaceutical industry, with the overall aims of launching novel therapies and improving the sector's international competitiveness.